Governance Generally. Up to three (3) voting committees (the JRC, JDC and JCC) may be formed, and three (3) non-voting teams (each, a JPT) will be set up, to govern and act as reporting bodies during the Term. Subsequently, an additional oversight committee (the JSC), and/or reporting body (AAC), may be established to provide an overarching governance structure as a Product progresses from development stage to commercial stage (depending on whether such Product includes a Selected Candidate or a Joint Selected Candidate).
Appears in 2 contracts
Samples: Development and License Agreement (Immunocore LTD), Development and License Agreement (Immunocore LTD)
Governance Generally. Up to three (3) voting committees (the JRCJSC, JDC and JCC) may be formed, and three (3) two non-voting teams (one for the Adaptimmune Candidate and one for the Bellicum Candidate; each, a JPT) will be set up, to govern and act as reporting bodies during the Term. Subsequently, an additional oversight committee (the JSC), and/or reporting body (AAC), may be established to provide an overarching governance structure as a Product progresses from development stage to commercial stage (depending on whether such Product includes a Selected Candidate or a Joint Selected Candidate).
Appears in 1 contract
Samples: Co Development and Co Commercialisation Agreement (Adaptimmune Therapeutics PLC)
Governance Generally. Up to three (3) voting committees (the JRCJSC, JDC and JCC) may be formed, and three (3) two non-voting teams (one for the Adaptimmune Candidate and one for the Bellicum Candidate; each, a JPT) will be set up, to govern and act as reporting bodies during the Term. Subsequently, an additional oversight committee (the JSC), and/or reporting body (AAC), may be established to provide an overarching governance structure as a Product progresses from development stage to commercial stage (depending on whether such Product includes a Selected Candidate or a Joint Selected Candidate).132265684 v23 Page 13
Appears in 1 contract
Samples: Co Development and Co Commercialisation Agreement (Bellicum Pharmaceuticals, Inc)